These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 7082826
1. The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. Carter CJ, Kelton JG, Hirsh J, Cerskus A, Santos AV, Gent M. Blood; 1982 Jun; 59(6):1239-45. PubMed ID: 7082826 [Abstract] [Full Text] [Related]
2. Antithrombotic and bleeding effects of a low molecular weight heparin fraction. Pangrazzi J, Abbadini M, Zametta M, Naggi A, Torri G, Casu B, Donati MB. Biochem Pharmacol; 1985 Sep 15; 34(18):3305-8. PubMed ID: 4038339 [Abstract] [Full Text] [Related]
3. A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation. Cade JF, Buchanan MR, Boneu B, Ockelford P, Cater CJ, Cerskus AL, Hirsh J. Thromb Res; 1984 Sep 15; 35(6):613-25. PubMed ID: 6506020 [Abstract] [Full Text] [Related]
4. In vivo effects of low molecular weight heparins on experimental thrombosis and bleeding. Hirsh J. Haemostasis; 1986 Sep 15; 16(2):82-6. PubMed ID: 3710297 [Abstract] [Full Text] [Related]
8. The haemorrhagic and antithrombotic effects of dermatan sulphate. Fernandez F, Van Ryn J, Ofosu FA, Hirsh J, Buchanan MR. Br J Haematol; 1986 Oct 15; 64(2):309-17. PubMed ID: 3778825 [Abstract] [Full Text] [Related]
9. Razaxaban, a direct factor Xa inhibitor, in combination with aspirin and/or clopidogrel improves low-dose antithrombotic activity without enhancing bleeding liability in rabbits. Wong PC, Crain EJ, Watson CA, Wexler RR, Lam PY, Quan ML, Knabb RM. J Thromb Thrombolysis; 2007 Aug 15; 24(1):43-51. PubMed ID: 17323133 [Abstract] [Full Text] [Related]
11. Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-III affinity heparin fraction. Ockelford PA, Carter CJ, Cerskus A, Smith CA, Hirsh J. Thromb Res; 1982 Sep 15; 27(6):679-90. PubMed ID: 7179209 [Abstract] [Full Text] [Related]
13. Comparative study on the in vitro and in vivo activities of seven low-molecular-weight heparins. Fareed J, Walenga JM, Hoppensteadt D, Huan X, Racanelli A. Haemostasis; 1988 Sep 15; 18 Suppl 3():3-15. PubMed ID: 2840372 [Abstract] [Full Text] [Related]
14. [Antithrombotic effects of low molecular weight heparin (FR-860) in rabbits]. Hamano S, Komatsu H, Ikeda S, Sakuragawa N. Nihon Yakurigaku Zasshi; 1989 Oct 15; 94(4):237-42. PubMed ID: 2613104 [Abstract] [Full Text] [Related]
15. Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits. Holmer E, Mattsson C, Nilsson S. Thromb Res; 1982 Mar 15; 25(6):475-85. PubMed ID: 7112507 [Abstract] [Full Text] [Related]
17. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits. Wong PC, Crain EJ, Watson CA, Zaspel AM, Wright MR, Lam PY, Pinto DJ, Wexler RR, Knabb RM. J Pharmacol Exp Ther; 2002 Dec 15; 303(3):993-1000. PubMed ID: 12438519 [Abstract] [Full Text] [Related]
18. The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin. Buchanan MR, Boneu B, Ofosu F, Hirsh J. Blood; 1985 Jan 15; 65(1):198-201. PubMed ID: 3965047 [Abstract] [Full Text] [Related]